Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 18/20 | 0.68 |
| ▸ | SIRT1 | Q96EB6 | 14/20 | 0.68 |
| ▸ | SIRT3 | Q9NTG7 | 6/20 | 0.68 |
| ▸ | CTSL | P07711 | 1/20 | 0.64 |
| ▸ | CTSS | P25774 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17244715 | 0.94 | SIRT5 (0.62) | SIRT2SIRT1SIRT3 | |
| SCHEMBL17694107 | 0.93 | CTSL (0.68) | SIRT2SIRT1SIRT3CTSLCTSS | |
| SCHEMBL28486381 | 0.91 | CTSL (0.63) | SIRT2SIRT1SIRT3CTSLCTSS | |
| SCHEMBL14157704 | 0.90 | SIRT2 (0.67) | SIRT2SIRT1SIRT3CTSLCTSS | |
| SCHEMBL18907026 | 0.90 | SIRT2 (0.67) | SIRT2SIRT1SIRT3CTSLCTSS | |
| SCHEMBL17435163 | 0.90 | SIRT2 (0.67) | SIRT2SIRT1SIRT3CTSLCTSS | |
| SCHEMBL14157706 | 0.90 | SIRT2 (0.67) | SIRT2SIRT1SIRT3CTSLCTSS | |
| SCHEMBL7133785 | 0.90 | SIRT2 (0.66) | SIRT2SIRT1SIRT3CTSLCTSS | |
| SCHEMBL17244714 | 0.89 | SIRT5 (0.60) | SIRT2SIRT1SIRT3 | |
| SCHEMBL9544530 | 0.89 | SIRT2 (0.57) | SIRT2SIRT1SIRT3CTSLCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170096449-A1 | Compositions and Methods Relating to Ionic Salts of Peptides | CONNECTICUT INNOVATIONS, INC., AS COLLATERAL AGENT | 2017-04-06 | — | — | US | disclosed |
| US-9505709-B2 | Compositions and methods relating to ionic salts of peptides | CONNECTICUT INNOVATIONS, INC., AS COLLATERAL AGENT | 2016-11-29 | — | — | US | disclosed |
| US-20160107985-A1 | Compositions and Methods Relating to Ionic Salts of Peptides | CONNECTICUT INNOVATIONS, INC., AS COLLATERAL AGENT | 2016-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170096449-A1 | Compositions and Methods Relating to Ionic Salts of Peptides | VIP, IAPP, NPPA | SIRT2 4703/4885SIRT1 4793/4885SIRT3 4500/4885 |
| US-20160107985-A1 | Compositions and Methods Relating to Ionic Salts of Peptides | VIP, IAPP, NPPA | SIRT2 4703/4885SIRT1 4793/4885SIRT3 4500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.